Shares of Blueprint Medicines Corporation
rose sharply in today's pre-market trading.
Sanofi SA
announced plans to acquire Blueprint Medicines for $9.5 billion.
Blueprint Medicines shares jumped 26.9% to $128.62 in the pre-market trading session.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.